Medicare Enrolled

Dr. Sam Hajal

Nephrology · Union City, NJ
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
510 31ST STREET, Union City, NJ 07087
2018663322
In practice since 2006 (19 years)
NPI: 1558450775 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Hajal from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Hajal? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Hajal

Dr. Sam Hajal is a nephrology specialist in Union City, NJ, with 19 years of NPI registration. Based on federal Medicare data, Dr. Hajal performed 4,096 Medicare services across 462 unique beneficiaries.

Between the years covered by Open Payments, Dr. Hajal received a total of $3,651 from 33 pharmaceutical and/or device companies across 207 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in nephrology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Hajal is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 10% volume in NJ $3,651 industry payments

Medicare Practice Summary

Medicare Utilization ↗
4,096
Medicare services
Top 10% in NJ for nephrology
462
Unique beneficiaries
$117
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~216 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
1,642 $102 $170
Nursing facility visit, moderate complexity
A follow-up visit by a healthcare provider at a nursing facility for an established patient. The visit involves moderate medical decision making and takes at least 30 minutes.
1,603 $92 $150
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
434 $152 $320
Dialysis services for patients 20 or older
Dialysis treatment provided to patients aged 20 years or older, involving four or more physician visits per month.
234 $294 $500
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
91 $145 $320
Initial nursing facility care, high complexity
An initial visit by a healthcare provider to a patient in a nursing facility involving a high level of medical decision making, lasting at least 45 minutes.
50 $156 $250
New patient office visit, complex (60-74 min) 42 $188 $375
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$3,651
Total received (2018-2024)
Avg $522/year across 7 years
Top 18% in NJ for nephrology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
33
Companies
207
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,634 (99.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$17 (0.5%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$735
2023
$471
2022
$216
2021
$434
2020
$232
2019
$720
2018
$843

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Aurinia Pharma U.S., Inc.
$125
Ardelyx, Inc.
$122
Bayer Healthcare Pharmaceuticals Inc.
$88
Otsuka America Pharmaceutical, Inc.
$85
Travere Therapeutics, Inc.
$72
AstraZeneca Pharmaceuticals LP
$65
Fresenius USA Marketing, Inc.
$45
OPKO Pharmaceuticals, LLC
$42
Boehringer Ingelheim Pharmaceuticals, Inc.
$34
AKEBIA THERAPEUTICS INC
$23
Renalytix AI, Inc.
$17
Amgen Inc.
$17
Top 3 companies account for 45.5% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$561
AKEBIA THERAPEUTICS INC
$457
Otsuka America Pharmaceutical, Inc.
$304
OPKO Pharmaceuticals, LLC
$244
Travere Therapeutics, Inc.
$227
Fresenius USA Marketing, Inc.
$217
Amgen Inc.
$195
Takeda Pharmaceuticals U.S.A., Inc.
$190
Vifor Pharma, Inc.
$172
Ardelyx, Inc.
$137
Bayer Healthcare Pharmaceuticals Inc.
$126
Aurinia Pharma U.S., Inc.
$125
Horizon Therapeutics plc
$118
Boehringer Ingelheim Pharmaceuticals, Inc.
$74
Relypsa, Inc.
$55
Mallinckrodt LLC
$50
Alexion Pharmaceuticals, Inc.
$46
Keryx Biopharmaceuticals, Inc.
$44
NxStage Medical, Inc.
$36
Bayer HealthCare Pharmaceuticals Inc.
$33
Horizon Pharma plc
$30
Retrophin, Inc.
$30
Daiichi Sankyo Inc.
$27
Allergan Inc.
$26
Renalytix AI, Inc.
$17
Novo Nordisk Inc
$16
Amarin Pharma Inc.
$15
Janssen Pharmaceuticals, Inc
$14
GENZYME CORPORATION
$14
Mallinckrodt Hospital Products Inc.
$14
Bard Peripheral Vascular, Inc.
$13
Otsuka Pharmaceutical Development & Commercialization, Inc.
$13
Merck Sharp & Dohme Corporation
$12
Top 3 companies account for 36.2% of all-time payments
Associated products mentioned in payments ›
(815) Thiola · ACTHAR · AURYXIA · Amitiza · Auryxia · Dialyzers · FABRY-DISEASE · FARXIGA · IBSRELA · INJECTAFER · INVOKANA · JARDIANCE · JYNARQUE · KIDNEYINTELX BLOOD COLLECTION CONVENIENCE KIT · KRYSTEXXA · Kerendia · LINZESS · LOKELMA · LUPKYNIS · LUTONIX · Ozempic · Parsabiv · RAYALDEE · Rayaldee · SAMSCA · System One · TAVNEOS · TRADJENTA · Thiola · ULTOMIRIS · Uloric · Ultomiris · Vascepa · Velphoro · Veltassa · XPHOZAH 30 MG · ZEPATIER
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a nephrology specialist in Union City?
Compare nephrologists in the Union City area by procedure volume, costs, and industry payment transparency.
Browse nephrologists nearby

Geographic Context

Nephrologists within 10 mi
725
Per 100K population
102.0
County median income
$90,032
Nearest hospital
CAREPOINT HEALTH-HOBOKEN UNIVERSITY MEDICAL CENTER
1.5 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Hajal is a mixed practice specialist, with above-average Medicare volume (top 10% in NJ), with low-engagement industry engagement in the top 18% of NJ peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Hajal experienced with hospital follow-up visit, high complexity?
Based on Medicare claims data, Dr. Hajal performed 1,642 hospital follow-up visit, high complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Hajal receive payments from pharmaceutical companies?
Yes. Dr. Hajal received a total of $3,651 from 33 companies across 207 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Hajal's costs compare to other nephrologists in Union City?
Dr. Hajal's average Medicare payment per service is $117. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Hajal) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →